148 related articles for article (PubMed ID: 4026901)
1. Cimetropium: characterization of antimuscarinic and spasmolytic properties.
Schiavone A; Schiavi GB; De Conti L; Micheletti R; Sagrada A; Hammer R; Giachetti A
Arzneimittelforschung; 1985; 35(5):796-9. PubMed ID: 4026901
[TBL] [Abstract][Full Text] [Related]
2. Effect of cimetropium bromide and other antispasmodic compounds on in vitro guinea-pig gallbladder.
Scarpignato C; Cartellá A; Zappia L
Methods Find Exp Clin Pharmacol; 1989 May; 11(5):323-9. PubMed ID: 2755278
[TBL] [Abstract][Full Text] [Related]
3. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
[TBL] [Abstract][Full Text] [Related]
4. Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes.
Carrier GO; Aronstam RS
J Pharmacol Exp Ther; 1990 Aug; 254(2):445-9. PubMed ID: 2384882
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antimuscarinic effect of cimetropium bromide in guinea pig ileum.
Saitoh N; Nishio H; Takeuchi T; Hata F
J Smooth Muscle Res; 1997 Feb; 33(1):1-9. PubMed ID: 9127842
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
Witkin JM; Gordon RK; Chiang PK
J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
[TBL] [Abstract][Full Text] [Related]
7. Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
Scarpignato C; Bianchi Porro G
Int J Clin Pharmacol Res; 1985; 5(6):467-77. PubMed ID: 3912339
[TBL] [Abstract][Full Text] [Related]
8. Effects of terflavoxate on stimulated contractions of urinary bladder in vitro.
Testa R; Guarneri L; Bernasconi P; Angelico P; Ibba M; Poggesi E; Meli A
Arzneimittelforschung; 1993 Feb; 43(2):122-8. PubMed ID: 8384453
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1517-26. PubMed ID: 7193020
[TBL] [Abstract][Full Text] [Related]
10. C14-aminosteroid LNF 209, an agent with positive inotropic and antimuscarinic activity.
Lüllmann H; Mohr K
J Cardiovasc Pharmacol; 1992; 20(5):807-12. PubMed ID: 1280745
[TBL] [Abstract][Full Text] [Related]
11. Antihistaminic and antimuscarinic effects of amitriptyline on guinea pig ileal electrolyte transport and muscle contractility in vitro.
Kachur JF; Allbee WE; Gaginella TS
J Pharmacol Exp Ther; 1988 May; 245(2):455-9. PubMed ID: 2896792
[TBL] [Abstract][Full Text] [Related]
12. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
[TBL] [Abstract][Full Text] [Related]
13. Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenonium.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1985 Mar; 232(3):732-40. PubMed ID: 2857786
[TBL] [Abstract][Full Text] [Related]
14. Species differences in the gut stimulatory effects of radish seeds.
Ghayur MN; Gilani AH; Houghton PJ
J Pharm Pharmacol; 2005 Nov; 57(11):1493-501. PubMed ID: 16259783
[TBL] [Abstract][Full Text] [Related]
15. Cimetropium bromide: in vitro and in vivo evaluation of spasmolytic activity on human and dog colon.
Sagrada A; Schiavone A; Cefalà A; Micheletti R
Digestion; 1989; 42(3):143-50. PubMed ID: 2767345
[TBL] [Abstract][Full Text] [Related]
16. Different effects of atropine and cimetropium bromide on gastric emptying of liquids and antroduodenal motor activity in man.
Imbimbo BP; Gardino L; Palmas F; Frascio M; Canepa G; Scarpignato C
Hepatogastroenterology; 1990 Apr; 37(2):242-6. PubMed ID: 2341121
[TBL] [Abstract][Full Text] [Related]
17. [The M-receptor antagonism of a new cholinolytic compounds TBBB in comparison with hyocine bromide (HBB) and atropine].
Dai DZ; Lin J; Wang LY; Zhang DL; Huang J; Xing WF
Yao Xue Xue Bao; 1986 Nov; 21(11):853-6. PubMed ID: 3591321
[No Abstract] [Full Text] [Related]
18. [The effect of quaternary derivatives of scopolamine (cimetropium bromide) on intestinal motility].
Sagrada A; Schiavone A; Cervo L; Giachetti A
Boll Chim Farm; 1986 Feb; 125(2):75-9. PubMed ID: 3741647
[No Abstract] [Full Text] [Related]
19. Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea-pig isolated uterus.
Boxall DK; Ford AP; Choppin A; Nahorski SR; Challiss RA; Eglen RM
Br J Pharmacol; 1998 Aug; 124(8):1615-22. PubMed ID: 9756376
[TBL] [Abstract][Full Text] [Related]
20. R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine.
Kachur JF; Peterson JS; Carter JP; Rzeszotarski WJ; Hanson RC; Noronha-Blob L
J Pharmacol Exp Ther; 1988 Dec; 247(3):867-72. PubMed ID: 2849672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
